Intas Pharmaceuticals has announced the appointment of Udit Sakhuja as Senior General Manager – Global New Product Launch. 

Prior to joining Intas, Sakhuja served at Dr. Reddy's Laboratories for over four years, where he held key leadership roles including Head of Marketing for Rheumatology and Ortho Biologics & Pain Management Portfolio, as well as Head of Marketing for NBE/NCE Innovative Oncology Assets.

Announcing the appointment via LinkedIn, Intas stated, “Udit brings with him over a decade of rich experience, with deep expertise in launching new products and managing them end-to-end — from gathering market insights and driving strategic planning to developing roadmaps and ensuring seamless execution.” 

“We look forward to his leadership as we continue to expand our global footprint with innovative, patient-centric solutions,” it added.

Before his tenure at Dr. Reddy’s, Sakhuja held the role of Deputy General Manager – Marketing at Zydus Cadila for five years. His diverse professional background also includes roles at Quest Diagnostics, Roche Products India Ltd., and Hoffmann-La Roche, along with experience at the Department of Sustainability and Environment in Victoria, Australia.

Sakhuja holds an MBA in Marketing from Deakin University, Australia.

Expressing his enthusiasm for the new role, Sakhuja said, “Thrilled to drive new product journeys at Intas with precision, passion and a purpose to deliver value.”

Intas is a vertically integrated global pharmaceutical formulation development, manufacturing, and marketing company. It has set up a network of subsidiaries, under the umbrella name of Accord Healthcare to operate in global markets.

It is currently present in more than 85 countries worldwide with robust sales, marketing and distribution infrastructure in markets like North America, Europe, Central and Latin America, Asia-Pacific as well as CIS and MENA countries.

The company is currently investing in a higher barrier to entry developments such as Biosimilar and New Chemical Entities.